A B S T R A C T The effect of testosterone (DT) and thyroxin (L-T4) on erythropoiesis and erythropoietin (Ep) These data demonstrate that (a) DT aind L-T4 are effective promnoters of extrarenal Ep production, thereby enhancing erythropoiesis in intact and nephrectomized fetuses; (b) DT is a stronger stimulus of extrarenal Ep formation than L-T4; and (c) Ep is required for the expression of the erythropoietic effects of L-T4 and DT.
INTRODUCTION
Erythropoiesis in the mammalian fetus and the adult is regulated by the hormone erythropoietin (Ep)l (1, 2) . Although Ep is produced mainly by the kidneys in the normal adult (3), a numl)er of sttudies have demonstrated the existence of extrarenal sources that, when appropriately stimulated, can produce about 5-10% of the Ep normally evoked in intact adults (4) . The most important extrarenal source of Ep in the adult is the liver (5) . By contrast, the liver represents the primary source of Ep during fetal and early neonatal periods (6, 7) . The production of Ep by the liver in the fetus-newborn is regulated by mechanisms similar to those that control renal Ep production in the adult (6, 7) . Thus hypoxia represents the fundamental erythropoietic stimulus for both organs (7) . The switch from hepatic to renal production of Ep, which occurs soon after birth, is accompanied by the effective loss of hepatic Ep formation. It is likely that the decline in hepatic Ep production is associated with increased maturity of the liver. However, the possibility that renal Ep exerts a suppressive influence on this aspect of liver function can not be ruled out. The decreased hepatic Ep production is apparent from the observations that an adequiate rate of erythropoiesis is not maintained in renoprival adults (8, 9) . Thus anemia is a fairly constant feature of renal dysfunction in man (10, 11) . Although erythrocyte abnormalities, chronic blood loss, deficiencies in certaini essential elements re(quired for heme synthesis, and inhibitors of erythropoiesis may be contributing factors, it is generally suspected that the underlying cause of the anemia in this disorder is a decrease in Ep production (11, 12) . A recent study employing plasma concentrates (13) has showni the presence of detectable levels of Ep in anephric patients (14) . However, the levels were significantly below those found in uiremicnephric patients with comparable degree of anemia.
Reactivation ofhepatic Ep formation can be achieved by exposure of the nephrectomized adult to hypoxiaproducing stimuli (4, 15) . However, studies with laboratory animals have shown that the intensity of hypoxia needed to activate the extrarenal site is significantly greater than that required by the kidneys (15) . Stimulation of hepatic Ep formation in renoprival adults is of considerable clinical interest because it may provide a more physiological approach to the treatment of the anemia in these individuals; normalization of erythropoiesis in uremic-anemic rats with chronic administration of Ep has been demonstrated (16) .
Androgens have been employed in the treatment of the anemia in some patients with chronic renal failure (17) (18) (19) (20) . The therapy has been generally more effective in patients with residual renal tissue (19) , but certain of the androgenic compounds have also been effective in some anephric patients receiving adequate hemodialysis (18) . In some patients with chronic renal failure (with or without residual renal tissue) the androgeninduced erythropoietic stimulation was accompanied by an increase in circulating Ep levels, whereas increased Ep levels were not demonstrated in others (17) (18) (19) . It is probable that in the latter group of patients, enhanced erythropoiesis was also associated with increased Ep production, which the relative insensitivity of the bioassay did not detect.
It is now firmly established that the erythropoietic effect(s) of androgens is mediated, at least in part, through increased production of Ep (21) (22) (23) . Studies employing nephrectomized adult animals have shown that this effect is dependent on the presence of kidneys (24) . However, the efficacy of androgens in promoting extrarenal Ep with confirmed dates of conception were obtained from local suppliers, observed, acclimated for at least 5 d, and then fasted for 24 h before surgery. Progesterone (Lipo-Lutin, 250 mg, Parke, Davis & Co., Detroit, Mich.) was administered intramuscularly on the day before surgery and daily thereafter. The studies were performed over a 2-yr period.
12 groups of five to eight fetuses each were established (Table I) . The fetuses in all groups were prepared for study by inserting a catheter into each of two fetal femoral arteries. The procedure for the placement of these intravenous catheters has been reported elsewhere (25) . In addition, each fettus in groups 4-12 was fitted with three separately placed subcutaneous catheters by creating pockets under the fetal skin and securing the catheters in these spaces. The following additional surgical procedures were performed at the time of catheter emplacement. Fetuses in groups 2 and 7-12 were bilaterally nephrectomized, while the fetuses in group 3 were subjected to partial hepatectomy (80-90% of liver removed). These operations were performed through a single ventral incision as described earlier (26) . The various catheters were clearly labeled and brought out through the uterus and maternal abdominal walls and secured to maternal skin. The amniotic fluid lost during surgery was replaced by warm isotonic saline containing antibiotics (25) . The uterus and abdominal walls were closed around these tubes in layers. Heparinized prewarmed sterile saline was used to maintain intravenous catheter flow. Ampicillin (250 mg) was injected daily into each fetus via the intravenous catheter to minimize the chance of infection (25) . The intravenous catheters were employed to obtain blood samples from the fetus and to administer radioiron and anti-Ep to the fetus. Subcutaneous catheters were used to administer thyroxin or testosterone, as well as the vehicle in which these hormones were dissolved. All animals except those in groups 1-3 were allowed to recover from surgery for 24 h before further treatment; groups 1-3 were allowed 4 h for recovery. The fetuses in groups 1-3 were rendered anemic by removing a 50-55 ml sample of blood (representing 42% of blood volume) from each fetus at the end of the recovery period. Plasmas from this initial bleeding served as control (0 h) samples.
The production of Ep in response to anemia in these groups was monitored by obtaining plasma from each fetus 12 h after the induction of anemia. The Ep activity of these and all other plasma samples were assayed in exhypoxic polycythemic mice. The plasma from each fetus was assayed separately (27) . 15 ml of hepariniized blood was ol)taine(l fromii each fetus in groutps [4] [5] [6] [7] [8] [9] [10] [11] [12] immediately after the recovery period anid was used to obtain pre-treatmeint (day 0) percenit reticulocytes, percenit hemiiatocrit, and plasmna Ep levels. Each fetus in groups 5, 8, and 11 was giveni suibcutaneous injections of 1.2 mlg thyroxin (L-T4) dissolved in 0.5 ml of the vehicle (0.0025 MI NaOH in saline)/d, 5 d/wk for a total of 13 injections. Eachi fettus in groups 6, 9, and 12 received subcutaneous injections of 12 mg of a long-acting preparation of testosterone (testosterone cyclopentylpropionate; depo-testosterone [DT]) once every week for 3 wk. Each dose of DT was dissolved in 1 ml of peanut oil. The animiials in groups 4, 7, and 10 served as controls and wvere given suhcutaneous injectionis of a mixture of 0.0025 M NaOH in salinie and peanut oil once every 3 d. The site of injectionis in groups 4-12 was changed wvith every dose by employing different subcutaneous catheters. 15-ml sanmples of heparinized blood were obtained from each fetus at intervals during the treatment period for reticulocyte, hematocrit, and Ep determiniations. These intervals are indicated in the tables.
The effect of L-T4 and DT on erytlhropoiesis in these fetuses was also monitored by admiiinistering 50 tCi[59Fe]Cl3 to each fetus via the intravenouis catheter 24 h after the last injection of the hormone. The radioiron was preincubated with 2 ml of the fetus's plasma for 30 min at 37°C before injection. Plasma used for this purpose was separated froml 5 ml of blood obtained from each fetus immediately before use. Percent incorporation of radioironi into fetal erhtyrocytes was determined 36 h later (2) . Blood volume of the fetus wvas assumed to be 5% of body weight, which was determined at the termination of the study. were given via the intravenous catheters. Reticulocyte numbers and percent erythrocyte-59Fe uptake were determined 36 h after the administration of radioiron.
RESULTS
Although five to eight fetuses were employed in each group, not all survived the various surgical and experimental procedures. The number of surviving animals in each group is indicated in legends to tables and the figure. It should be pointed out, however, that all but one of these fetuses died within the first 72 h of the study; one fetus died 8 d after surgery. None of these losses can be attributed to the effect of nephrectomy.
In general, it has been shown that the kidney is niot necessarily essential to the survival ofthe fetus, although the overall growth may be somewhat retarded (28) . This unique fetal characteristic has permitted these studies. The nephrectomized fetuses in these studies exhibited moderate increases in creatiiiine and blood urea nitrogen levels (creatinine: Table III demonstrate that this increase in Ep production was accompanied by enhaniced erythropoiesis in treated fetuses. Generally, elevated reticulocyte and hematocrit values were noted in DT and L-T4 treated normal and nephrectomized fetuses. Increased reticulocyte numbers were first detected on day 7 of treatment and remained elevated throughout the study period. Significantly increased erythropoiesis was also evident from the increased incorporation of radioiron into erythrocytes of the hormone-treated fetuses (Table III) .
Results presented in
Hormonal Stimulation of Erythr-opoiesis in Aniephric Fetuises The results presented in Fig. 1 (groups 10-12) demonstrate the pivotal role of Ep in the mediationi of the erythropoietic effects of L-T4 and DT in nephrectomized fetuses. Near total inhibition of erythropoiesis was seen when circulating Ep in these fetuses was neutralized by the administration of anti-Ep. Control values shown in Fig. 1 were derived from fetuses in groups 7-9. These fetuises were given injections of normal rabbit serum-i using procedures similar to those described for the administratioin of the antibody to groups 10-12. We have previously reported (2) that the administration of similar anmiounts of normal rabbit serum to sheep fetuses did not appreciably affect any of the erythropoietic parameters reported here.
To assess the influence of the treatmenit of' the fetus on maternial erytlhropoiesis, maternal plasma samples obtained at intervals shown for the fetuses were assayed for Ep activity in polycythemic miice. No detectable rise in maternial Ep activity was noted throughout the study period. Moreover, maternal reticulocyte and hematocrit values remained uinchanged.
DISCUSSION
The results here demiionstrate that the adimiinistrationi of DT and L-T4 to fetal sheep during the last trimester of gestation resuilts in increased production of erythrocytes. This was evident not only from increased incorporation of radioiron into the circutlating erythrocytes, but also from elevated numbners of circulating reticulocytes and generally increased hematocrit valtues. The expression of the erythropoietic effects of DT and L-T4 in these fetuses was dependent uipon the presence of Ep and was mediated, at least in part, through increased production of Ep. In this regard, plasmas from DT-and L-T4-treated fetuses exhibited significant erythropoiesis-stimulatory activity in exhypoxic polycytheinic mice. That this effect of the fetal plasma was catused by the presence of' elevated Ep levels was demonstrated by the fact that pretreatmiient of the plasma with anti-Ep completely neutralized its erythropoietic activity. Moreover, coinplete inhibition of in vivo erythropoiesis was achieved in control, as well as DT-and (2) , and point to the similarities in the regulation of erythropoiesis between the fetus and the adult (29) . In these studies, despite the use of pharmacological doses of these hormones, the erythropoietic influences of DT and L-T4 were confined to the fetus; maternal erythropoietic statuis remained unaltered during the study period. This is in accord with reported observations that little, if any, transplacental passage of DT, L-T4, and Ep occurs in sheep (29, 30) . Stimulation of erythropoiesis in the adult by DT and L-T4 has been well documenited (21) (22) (23) (31) (32) (33) (34) . Like the fetus, the erythropoietic response of the adult to these hormones is mediated by Ep (31, 33, 34) . Furthermore, this effect of androgens in the adult is dependent on the presence of the kidney (24) . The mechanism underlying the androgen effect on Ep production is not known. In the fetus, however, the manifestation of the erythropoietic effects of DT and L-T4 did not require the presence of the kidneys. Administration of DT and L-T4 to bilaterally nephrectomized fetuses resulted in the enhancement of erythropoiesis and Ep production similar to that observed in fetuses with intact kidneys; this response was totally abolished by injections of anti-Ep.
Since the early classic studies of Jacobsen et al. (3) , the kidney has been acknowledged to be the primary site of Ep production in adult mammals. However, in inost species, smnall but detectable amounts of Ep are produced in the absence of both kidneys (3, 4, 35) . The overwhelming evidence suggests that the liver is the major source of this extrarenal Ep (5, 36) . The cellular origin of extrarenal Ep is not known. Studies by Peschle et al. (37) have imnplicated the reticuiloendothelial systemii (including the Ktupffer cell) in extrarenal Ep formiationi, wvhereas Erslev et al. (38) suggest that the hepatocyte miay be involved. Results described here, in agreemnent with earlier observations (6), demonstrate that the liver, rather than the kidney, is the primary source of Ep in the fetuis. The switch to renal predomiiinance occurs somiietimie during the early neonatal period anid is associated with the degree of neoniatal maturity (39, 40) . Thus the liver, active during fetal life, becomes dorinaiit in the adult whien the kidney assumes the primary role in Ep production. However, the hepatic system miay become reactivated duriing periods of renal noinfuinction and/or absenice to once again resumlle Ep production (5, 36) .
Unlike the kidney in the adult and the liver in the fetus, which produce adequate amounits of Ep in response to normal day-to-day needs, hepatic reactivation does not occur in the absence of above normal levels of stimulationi. In bilaterally nephrectomized laboratory aniimals, the activationi of extr-arenal Ep formation requiires a greater intensity of hypoxia than the kidney needs for Ep formation (15) . In the isolated cases of renoprival man where detectable Ep levels were noted, it was preceded by severe anemia (12, 41) . In this regard, experimenits by Ersley et al. (38) indicate that in the presence of severe hypoxic stress, extrarenal Ep production may reach levels comparable to those of renal formation. In a miajority of clinical cases, 110W-ever, hepatic reactivation does not occur, and an adequate rate of erythrocyte production is not mlaintained in most patients with renal failure (10, 11) .
The results of the present sttudy demonistrate that the extrarenial site of Ep formation is responisive to the same regulatory forces that affect renal Ep production. Thuis DT aind L-T4 are effective promoters of hepatic Ep formation in fetal sheep. Moreover, these results for the first time provide definitive experimnental evidence in support of continuing the use of hormonal agents suich as aindrogens in attempts to reactivate hepatic Ep production in anephric aduilts. It shouild be noted that in several clinical trials, androgens halve not been particularly effective in anephric patients, perhaps because of the absence of optimal conditions. Further studies are re(quired to determiiine the optimal condition(s) under which milaximilal stimuliationi ofhepatic Ep production in adults in response to androgeins occurs. In our studies, the degree of DT-and L-T4-induced stimulation of Ep production in the fetuLs was generally comparable to that seen in intact adults (uin-published observations, based on studies in two adult female sheep). However, the relative increase in Ep formation in anephric adults in response to androgen therapy is significantly less than when the kidneys are present (18) . Thus additional steps may be needed to maximize the hepatic response to these hormones in the adult. In this regard, it has been demonstrated that exposure of DT-and L-T4-treated adult animals to hypoxic stimuli results in a synergistic (rather than additive) effect on Ep formation (42) .
